Background and Aims Gastric cancer (GC) is a prevalent gastrointestinal malignancy, yet its early detection remains hindered due to the lack of available genetic markers. This study aimed to identify alternative genetic markers for the early prognosis and prevention of GC.4 PODCAST EXCLUSIVE TO THE ONCOLOGY NETWORK | LISTEN NOW Methods This objective was achieved ..read more

Ann & Robert H. Lurie Children’s Hospital of Chicago, USA, is pleased to announce the first paediatric use of the novel fluorescent agent CYTALUX during surgery to remove lung metastases. The drug allows surgeons to better visualise cancer in the lung, as well as potentially detect additional cancerous nodules missed by preoperative imaging. This drug ..read more

When Ana Ratapu was diagnosed with melanoma, she had to fight hard to get life-saving treatment. Now, as a member of Melanoma and Skin Cancer Trials Consumer Advisory Panel, Ana is working to remove those barriers and ensure those in need can access the highest standards of care. In 2020, Ana and her family were ..read more

Adding a pre-ketone supplement — a component of a high-fat, low-carb ketogenic diet — to a type of cancer therapy in a laboratory setting was highly effective for treating prostate cancer, researchers from the University of Notre Dame, USA, found. Recently published online in the journal Cancer Research, the study from Xin Lu, the John M. and Mary Jo ..read more

A team of researchers from Aarhus University, Denmark, has made a remarkable discovery that could improve cancer treatment and the treatment of a number of other illnesses. The key lies in regulating cholesterol levels, which can help make existing treatments more effective. “We’ve identified a new mechanism that can regulate a crucial immune pathway in ..read more

Local and global experts are meeting in Nairobi, Kenya to update clinical practice guidelines as part of ongoing work with Allied Against Cancer – a collaboration between the National Comprehensive Cancer Network (NCCN), African Cancer Coalition (ACC), American Cancer Society (ACS), and Clinton Health Access Initiative (CHAI). The meeting brings together subject matter experts to ..read more

For the first time, researchers from VIB-KU Leuven, UZ Leuven, Belgium, and multiple international collaborators have introduced quantitative methods and extensive confounder control to discover microbiome biomarkers in colorectal cancer development. While multiple microbial taxa have been put forward as potential cancer-associated biomarkers in the past, this new study uncovers obscured contributions that may have ..read more

Social isolation is a difficult experience for many people and was particularly distressing during the COVID19 pandemic. For adolescents who are immunocompromised, physical distancing can be important in managing their risk of serious infection, but it can be an especially negative experience during some of their most formative years. A recent study by Dr. Lindsay ..read more

In a first-ever human clinical trial of four adult patients, an mRNA cancer vaccine developed at the University of Florida, USA, quickly reprogrammed the immune system to target glioblastoma. The results mirror those in 10 pet dog patients suffering from naturally occurring brain tumours whose owners approved of their participation, as they had no other ..read more

VCCC Alliance Chief Executive, Professor Grant McArthur AO has welcomed today’s announcement from Federal Minister for Health and Aged Care, The Hon Mark Butler MP, to invest in a $1.89 billion Health Research for a Future Made in Australia package and the development of a new National Health and Medical Research Strategy. In particular, Prof McArthur applauded ..read more